Market Overview:
The global African trypanosomiasis market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The market growth is attributed to the increasing prevalence of African trypanosomiasis, rising demand for early diagnosis and treatment, and growing awareness about the disease. Based on type, the global African trypanosomiasis market is segmented into Trypanosoma Brucei Rhodesiense and Trypanosoma Brucei Gambiense. The Trypanosoma Brucei Rhodesiense segment is expected to grow at a higher CAGR during the forecast period owing to its high prevalence in Africa. Based on application, the global African trypanosomiasis market is segmented into blood samples, bone marrow, lymph node fluid, cerebrospinal fluid or lymph node aspirate. The blood samples segment accounted for the largest share of the global African trypanosomiasis market in 2017 and it is projected to maintain its dominance during the forecast period.
Product Definition:
African Trypanosomiasis is a parasitic disease caused by the protozoan parasite, Trypanosoma brucei gambiense orTrypanosoma brucei rhodesiense. The parasites are spread through the bite of an infected tsetse fly. African trypanosomiasis is also known as sleeping sickness.
Trypanosoma Brucei Rhodesiense:
The African trypanosomiasis market is expected to grow at a lucrative rate during the forecast period. The major factor that propels the growth of this market includes an increase in demand for medicines and medical procedures due to rising incidences of diseases such as sleeping sickness, Chagas disease, and leprosy. Moreover, increasing awareness among people regarding these diseases leads them to spend more on healthcare products which further boosts the revenue generation capacity of pharmaceutical companies operating in this sector.
Trypanosomiasis Brucei Gambiense:
African trypanosomiasis is a disease caused by parasitic protozoon, which is transmitted to humans through the bite of infected tsetse fly. The disease causes sleeping sickness or konzo and has three stages namely; acute, sub-acute and chronic.
Application Insights:
The market is categorized into blood samples, bone marrow, lymph node fluid or aspirate and cerebrospinal fluid or lymph node as a sample. The cerebrospinal fluid or lymhnode as a sample segment held the largest share in 2017 owing to the rising prevalence of neurological disorders coupled with an increase in the adoption of diagnostic measures such as spinal taps for diagnosis. According to data published by WHO in 2018, more than 50 million people suffer from epilepsy globally and approximately 2 million people are diagnosed with epilepsy every year. This represents an opportunity for Africa trypanosomiasis market players who are engaged in producing affordable generic drugs that target this population segment at low cost.
Blood samples were estimated to be the fastest-growing application segment during forecast years due to increasing usage of blood sampling techniques for diagnosis across various disease states such as HIV/AIDS, dengue hemorrhagic fever.
Regional Analysis:
The African trypanosomiasis market is mainly dominated by the countries in the Western Africa sub-region. The disease is prevalent in over 50 countries across six different African regions namely, West Africa, Central Africa, East & South Sudan (SSA), East & North Sudan (Nuba) South Arabia and Somalia. In 2017, these regions together accounted for more than 95% of the global market share owing to a large number of affected people and high prevalence rates coupled with a weak healthcare infrastructure.
Growth Factors:
- Increasing prevalence of African trypanosomiasis: The global prevalence of African trypanosomiasis is estimated to be around 50,000 cases. However, the actual number of cases could be much higher as many cases go undetected or are misdiagnosed. The increasing prevalence of the disease is expected to drive the growth of the African trypanosomiasis market in the coming years.
- Growing awareness about African trypanosomiasis: There is a growing awareness about African trypanosomiasis among people across the globe. This is mainly due to increased research and media coverage on this topic in recent years. Increased awareness will help drive demand for diagnosis and treatment options for this disease, thereby propelling market growth in the coming years.
- Rising incidence of sleeping sickness: Sleeping sickness (also known as human african Trypanosomiasis) caused by protozoan parasites transmitted by tsetse flies is a major public health concern in Africa .The rising incidence of sleeping sickness will lead to an increase in demand for diagnosis and treatment options for this deadly disease, fueling market growth over the forecast period .
Scope Of The Report
Report Attributes
Report Details
Report Title
African Trypanosomiasis Market Research Report
By Type
Trypanosoma Brucei Rhodesiense, Trypanosomiasis Brucei Gambiense
By Application
Blood Samples, Bone Marrow, Lymph Node Fluid, Cerebrospinal Fluid or Lymph Node Aspirate
By Companies
Sanofi, Genzyme Corporation, aRigen Pharmaceuticals, Immtech Pharmaceuticals, Anacor Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
195
Number of Tables & Figures
137
Customization Available
Yes, the report can be customized as per your need.
Global African Trypanosomiasis Market Report Segments:
The global African Trypanosomiasis market is segmented on the basis of:
Types
Trypanosoma Brucei Rhodesiense, Trypanosomiasis Brucei Gambiense
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Blood Samples, Bone Marrow, Lymph Node Fluid, Cerebrospinal Fluid or Lymph Node Aspirate
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sanofi
- Genzyme Corporation
- aRigen Pharmaceuticals
- Immtech Pharmaceuticals
- Anacor Pharmaceuticals
Highlights of The African Trypanosomiasis Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Trypanosoma Brucei Rhodesiense
- Trypanosomiasis Brucei Gambiense
- By Application:
- Blood Samples
- Bone Marrow
- Lymph Node Fluid
- Cerebrospinal Fluid or Lymph Node Aspirate
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the African Trypanosomiasis Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
African trypanosomiasis is a parasitic disease caused by the Trypanosoma brucei parasite. The disease is found in Africa, the Middle East, and parts of Asia. African trypanosomiasis can cause serious health problems including death.
Some of the key players operating in the african trypanosomiasis market are Sanofi, Genzyme Corporation, aRigen Pharmaceuticals, Immtech Pharmaceuticals, Anacor Pharmaceuticals.
The african trypanosomiasis market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 African Trypanosomiasis Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 African Trypanosomiasis Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 African Trypanosomiasis Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the African Trypanosomiasis Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global African Trypanosomiasis Market Size & Forecast, 2018-2028
4.5.1 African Trypanosomiasis Market Size and Y-o-Y Growth
4.5.2 African Trypanosomiasis Market Absolute $ Opportunity
Chapter 5 Global African Trypanosomiasis Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 African Trypanosomiasis Market Size Forecast by Type
5.2.1 Trypanosoma Brucei Rhodesiense
5.2.2 Trypanosomiasis Brucei Gambiense
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global African Trypanosomiasis Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 African Trypanosomiasis Market Size Forecast by Applications
6.2.1 Blood Samples
6.2.2 Bone Marrow
6.2.3 Lymph Node Fluid
6.2.4 Cerebrospinal Fluid or Lymph Node Aspirate
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global African Trypanosomiasis Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 African Trypanosomiasis Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America African Trypanosomiasis Analysis and Forecast
9.1 Introduction
9.2 North America African Trypanosomiasis Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America African Trypanosomiasis Market Size Forecast by Type
9.6.1 Trypanosoma Brucei Rhodesiense
9.6.2 Trypanosomiasis Brucei Gambiense
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America African Trypanosomiasis Market Size Forecast by Applications
9.10.1 Blood Samples
9.10.2 Bone Marrow
9.10.3 Lymph Node Fluid
9.10.4 Cerebrospinal Fluid or Lymph Node Aspirate
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe African Trypanosomiasis Analysis and Forecast
10.1 Introduction
10.2 Europe African Trypanosomiasis Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe African Trypanosomiasis Market Size Forecast by Type
10.6.1 Trypanosoma Brucei Rhodesiense
10.6.2 Trypanosomiasis Brucei Gambiense
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe African Trypanosomiasis Market Size Forecast by Applications
10.10.1 Blood Samples
10.10.2 Bone Marrow
10.10.3 Lymph Node Fluid
10.10.4 Cerebrospinal Fluid or Lymph Node Aspirate
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific African Trypanosomiasis Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific African Trypanosomiasis Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific African Trypanosomiasis Market Size Forecast by Type
11.6.1 Trypanosoma Brucei Rhodesiense
11.6.2 Trypanosomiasis Brucei Gambiense
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific African Trypanosomiasis Market Size Forecast by Applications
11.10.1 Blood Samples
11.10.2 Bone Marrow
11.10.3 Lymph Node Fluid
11.10.4 Cerebrospinal Fluid or Lymph Node Aspirate
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America African Trypanosomiasis Analysis and Forecast
12.1 Introduction
12.2 Latin America African Trypanosomiasis Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America African Trypanosomiasis Market Size Forecast by Type
12.6.1 Trypanosoma Brucei Rhodesiense
12.6.2 Trypanosomiasis Brucei Gambiense
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America African Trypanosomiasis Market Size Forecast by Applications
12.10.1 Blood Samples
12.10.2 Bone Marrow
12.10.3 Lymph Node Fluid
12.10.4 Cerebrospinal Fluid or Lymph Node Aspirate
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) African Trypanosomiasis Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) African Trypanosomiasis Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) African Trypanosomiasis Market Size Forecast by Type
13.6.1 Trypanosoma Brucei Rhodesiense
13.6.2 Trypanosomiasis Brucei Gambiense
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) African Trypanosomiasis Market Size Forecast by Applications
13.10.1 Blood Samples
13.10.2 Bone Marrow
13.10.3 Lymph Node Fluid
13.10.4 Cerebrospinal Fluid or Lymph Node Aspirate
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 African Trypanosomiasis Market: Competitive Dashboard
14.2 Global African Trypanosomiasis Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sanofi
14.3.2 Genzyme Corporation
14.3.3 aRigen Pharmaceuticals
14.3.4 Immtech Pharmaceuticals
14.3.5 Anacor Pharmaceuticals
